201 related articles for article (PubMed ID: 18520048)
21. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
22. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
[TBL] [Abstract][Full Text] [Related]
23. Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeys.
Horai N; Nagaoka T; Higuchi I; Kasai H; Yoshioka T; Umekita Y; Fukuzaki K; Nagata R; Miyata A; Abeyama K
BMC Musculoskelet Disord; 2013 Jul; 14():205. PubMed ID: 23834772
[TBL] [Abstract][Full Text] [Related]
24. Effects of SA237, a humanized anti-interleukin-6 receptor monoclonal antibody, on pre- and postnatal development in cynomolgus monkey.
Katagiri R; Ishihara-Hattori K; Frings W; Amano J; Fuchs A; Chiba S
Birth Defects Res; 2017 Jul; 109(11):843-856. PubMed ID: 28504465
[TBL] [Abstract][Full Text] [Related]
25. Suppression of experimental arthritis with self-assembling glycol-split heparin nanoparticles via inhibition of TLR4-NF-κB signaling.
Babazada H; Yamashita F; Hashida M
J Control Release; 2014 Nov; 194():295-300. PubMed ID: 25242730
[TBL] [Abstract][Full Text] [Related]
26. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis.
Andersson AK; Sumariwalla PF; McCann FE; Amjadi P; Chang C; McNamee K; Tornehave D; Haase C; Agersø H; Stennicke VW; Ahern D; Ursø B; Trowsdale J; Feldmann M; Brennan FM
Arthritis Rheum; 2011 Sep; 63(9):2617-29. PubMed ID: 21618462
[TBL] [Abstract][Full Text] [Related]
27. Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.
Yokota S; Miyamae T; Imagawa T; Katakura S; Kurosawa R; Mori M
Clin Rev Allergy Immunol; 2005 Jun; 28(3):231-8. PubMed ID: 16129907
[TBL] [Abstract][Full Text] [Related]
28. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
[TBL] [Abstract][Full Text] [Related]
29. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
Snir A; Kessel A; Haj T; Rosner I; Slobodin G; Toubi E
Clin Exp Rheumatol; 2011; 29(4):697-700. PubMed ID: 21813064
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the In Vivo Performance of a Monoclonal Antibody to Neutralize Its Soluble Target at the Site of Action in a Mouse Collagen-Induced Arthritis Model.
Wang W; McIntosh TS; Jiang X; Doddareddy R; Dell EC; Zhou H
Pharm Res; 2016 Apr; 33(4):1040-9. PubMed ID: 26718954
[TBL] [Abstract][Full Text] [Related]
31. Anti-interleukin-6 receptor antibody therapy in rheumatic diseases.
Nakahara H; Nishimoto N
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):373-81. PubMed ID: 17214583
[TBL] [Abstract][Full Text] [Related]
32. A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential.
Liu X; Li L; Wang Q; Jiang F; Zhang P; Guo F; Liu H; Huang J
Front Immunol; 2021; 12():816646. PubMed ID: 35126375
[TBL] [Abstract][Full Text] [Related]
33. Crocin exerts anti-inflammatory and anti-arthritic effects on type II collagen-induced arthritis in rats.
Liu W; Sun Y; Cheng Z; Guo Y; Liu P; Wen Y
Pharm Biol; 2018 Dec; 56(1):209-216. PubMed ID: 29540097
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress.
Sharma S; Sahu D; Das HR; Sharma D
Food Chem Toxicol; 2011 Dec; 49(12):3395-406. PubMed ID: 21983485
[TBL] [Abstract][Full Text] [Related]
35. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
36. The establishment of a rheumatoid arthritis primate model in Macaca fascicularis.
Na HS; Lee SY; Min HK; Park WJ; Lee JH; Cho KH; Hong SH; Kim DH; Jhun J; Choi JW; Kim SM; Kwok SK; Cho ML; Park SH
J Transl Med; 2020 Jun; 18(1):264. PubMed ID: 32605610
[TBL] [Abstract][Full Text] [Related]
37. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin exerts a potent anti-arthritic effect and insulin resistance in collagen-induced arthritic rats.
Wu D; Hua B; Fang Z; Liu J; Liu N; Ma Y
Int J Rheum Dis; 2018 Aug; 21(8):1496-1503. PubMed ID: 28752573
[TBL] [Abstract][Full Text] [Related]
39. The inhibitory effect of tocilizumab on systemic bone loss and tendon inflammation in a juvenile Collagen-Induced arthritis rat model.
Poutoglidou F; Pourzitaki C; Manthou ME; Samoladas E; Saitis A; Malliou F; Kouvelas D
Connect Tissue Res; 2022 Nov; 63(6):577-589. PubMed ID: 35175165
[TBL] [Abstract][Full Text] [Related]
40. The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody.
Mihara M; Nishimoto N; Ohsugi Y
Expert Opin Biol Ther; 2005 May; 5(5):683-90. PubMed ID: 15934843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
